CBF Cord Blood Forum

A continuously changing selection of articles

  1. Recent Reviews

    Citation #1. Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome    . Tomblyn MB, Arora M, Baker KS, Blazar BR, et al. J Clin Oncol. 2009 27;22:3634-3641.

    Citation #3. Disease-Free Survival After Cord Blood (CB) Transplantation Is Not Different to That After Related or Unrelated Donor Transplantation in Patients with Hematologic Malignancies. Doris Ponce, Junting Zheng, Anne Marie Gonzales, et al. Blood 2009;114:906 (Abstract 2296)
  1. Multi-Cord Transplants

    Citation #5. Double umbilical cord blood transplantation. Majhail NS, Brunstein CG, Wagner JE. Curr Opin Immunol. 2006; 18: 1-5.

    Citation #4. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplant outcomes in 110 adults with hematological disease. Brunstein CG, Barker JN, Weisdorf DJ, Defor TE, Miller JS, Blazar BR, McGlave PB, Wagner JE. Blood. 2007;110:3064-3070.

  2. Reduced Intensity and Non-Myeloablative Transplants

    Citation #1: Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease.     Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, Childs RW, Rodgers GP, Powell JD, Tisdale JF. New Eng J Med 2009;361:2309-2317.

    Citation #3. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor. Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, Arora M, Kaufman DS, Burns LJ, Slungaard A, McGlave PB, Wagner JE, Weisdorf DJ. Biol Blood Marrow Transplant. 2008;14:282-9.

  3. Donor Selection for Unrelated Cord Blood Transplantation

    Citation # 3. Reexposure of cord blood to non-inherited maternal HLA antigens improves transplant outcome in hematologic malignancies.     van Rood JJ, Stevens CE, Smits J, Carrier C, Caarpenter C, Scaradavou A. Proc Natl Acad Sci USA. 2009;106:19952-7.

    Citation #3: Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors. Rocha V, Gluckman E; Eurocord-Netcord registry and European Blood and Marrow Transplant group. Br J Haematol. 2009;147:262-274.
  1. Cord Blood Banking i. Overview

    Citation #1. Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment? van Rood JJ, Oudshoorn M. Bone Marrow Transplant. 2008;41:1-9. Is it cost-effective to continue to add donors to the adult registries? (Clue: the Sorcerer’s Apprentice has been invoked as a colorful answer to this question.)